USPTO serial 79270865
JIIQARGO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 13, 2020
- Examiner
- CAHILL, CLARE GALLAGHER
- Law office
- TMEG LAW OFFICE 104
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with JIIQARGO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher I. Donahue
Christopher I. Donahue Oblon McClelland Maier & Neustadt LLP1940 Duke StreetAlexandria, VA 22314UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the treatment of peripheral nervous system disorders; pharmaceutical preparations for the treatment of growth deficiencies; pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of Fabry disease, Gaucher disease, GM1 Gangliosidosis, GM2 Gangliosidosis, Krabbe disease, Niemann-Pick disease, Metachromatic leukodystrophy, Hurier syndrome, Hunter disease, Sanfilippo syndrome, Morquio syndrome, Sly syndrome, Pompe disease, Alfa-mannosidosis disease, Fucosidosis disease, and Neuronal ceroid lipofuscinosis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by JCR Pharmaceuticals Co., Ltd.
- Other trademarks owned by JCR Pharmaceuticals Co., Ltd.
- Other trademarks owned by JCR Pharmaceuticals Co., Ltd.
- Other trademarks in Class 005
- Similar marks named JIIQARGO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 20, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 30, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 30, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 13, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 13, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 31, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 28, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 28, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 15, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 8, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 23, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 16, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 16, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 15, 2020 | ALIE | ASSIGNED TO LIE | — |
| Feb 21, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 21, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 21, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 21, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 21, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 30, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 30, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 12, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 9, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 8, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 8, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 31, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |